EIX vs MNPR · P/E 7.3, rev $17.60B vs $431.4M cap
Edison International (EIX) versus Monopar Therapeutics Inc (MNPR) — a side-by-side from cached financials, not a winner call.
Edison International (EIX) is a utilities - regulated electric company listed on US.
Monopar Therapeutics Inc (MNPR) is a biotechnology company listed on US.
Latest reported EIX revenue for 2024-12-31 was $17.60B. Net income was $1.55B. Revenue was up 7.7% from 2023-12-31 to 2024-12-31. EIX currently screens at market cap $19.73B and trailing P/E 7.3.
Latest reported MNPR revenue for 2024-12-31 was $0. Net income was -$15.6M. MNPR currently screens at market cap $431.4M.
EIX currently screens at market cap $19.73B and trailing P/E 7.3. MNPR currently screens at market cap $431.4M.
Not investment advice. Open the EIX and MNPR stock pages for the full models.
Not investment advice.